The daily equity report from CapitalStars Financial Research provides an overview of the Indian and global stock markets. In India, the key indices ended higher led by gains in pharmaceutical stocks like Lupin and Ranbaxy after their better-than-expected quarterly earnings. Asian markets closed mixed while European shares rose. In the Indian market, Sun Pharma, Cipla and Tata Power were the top gainers while Lupin, Bharti Airtel and HeroMotoCorp lost the most value.

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
DAILY EQUITY REPORT 29TH October 2014

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report INDIAN MARKET
INDIAN FACE
 INDIAN EQUITY BENCHMARK ended higher on Tuesday, ahead of the two-day US Federal Reserve Open Market Committee meet, led by Pharma shares after better-than- expected second quarter earnings from Lupin and Ranbaxy boosted sentiment.
 Further, Texmaco Rail & Engineering closed up 1.51% on new acquisitions and major orders. The company's net profit declined 44% to Rs33.2 million for the second quarter ended 30 September 2014 from Rs59.3 million in the same quarter last fiscal.
 Shares of L&T edged higher by 0.5% to close at Rs1575 after the company received Rs 2,989-crore order to erect Sardar Patel's Statue of Unity.
GLOBAL FACE
 Asian markets closed mixed with Japanese stocks down around 0.4% after dismal results from Canon Inc. raised concerns about corporate earnings.
 European shares rose in early trade on Tuesday, reversing the previous session's dip as better-than-expected results from a number of blue-chips including Pharma group Novartis and bank UBS helped lift sentiment.
 US stock index futures poised for a higher opening at the Wall Street on Tuesday.
INDICES
CLOSE
PREVIOUS
SENSEX
26,880.82
26,752.90
NIFTY
8,027.60
7,991.70 ASIAN MARKET
INDICES
CLOSE
PREVIOUS
NIKKEI
15,329.91
15,388.72
HANG SENG
23,520.36
23,143.23
KOSPI
1,925.68
1,931.97 SECTORIAL INDICES
INDICES
CLOSE
CHANGE (%)
CNX 100
7,973.15
0.43
S&P CNX 500
6,465.15
0.41
CNX MIDCAP
11,536.95
0.54
CNX 200
4,092.20
0.43
BANK NIFTY
16,667.00
0.67 TOP GAINERS
SCRIPT
CLOSE
CHANGE (%)
SUN PHARMA
841.90
4.56
CIPLA
648.00
3.17
TATA POWER
90.75
2.60
BPCL
703.90
2.59 TOP LOSERS
SCRIPT
CLOSE
CHANGE (%)
LUPIN
1,359.05
-2.45
BHARTIARTL
406.85
-1.86
HEROMOTOCO
3,040.00
-1.39
PNB
921.00
-1.24

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report MARKET MOVERS UPSIDE
NIFTY SPOT TREND STRATEGY
BEARISH
SELL ON HIGH PIVOT POINTS
S3
S2
S1
P
R1
R2
R3
7934
7977
8002
8020
8045
8062
8105 NIFTY SUPPORT RESISTANCE
S1-7970
R1-8065
S2-7870
R2-8160 BANK NIFTY FUTURE TREND STRATEGY
BULLISH
BUY ON DIPS PIVOT POINTS
S3
S2
S1
P
R1
R2
R3
16460
16568
16634
16676
16741
16783
16891 BANK NIFTY SUPPORT RESISTANCE
S1-16600
R1-16720
S2-16480
R2-16900
SCRIPT
CLOSE
CHANGE (%)
TCS
2478.60
0.87
ITC
350.15
0.17
COAL INDIA
356.65
0.04
SBIN
2656.75
2.27 MARKET MOVERS DOWNSIDE
SCRIPT
CLOSE
CHANGE (%)
ONGC
391.70
[0.75]
RELIANCE
934.05
[0.78]
INFOSYS
3788.25
[0.39]
HDFC BANK
895.30
[0.22] FII & DII ACTIVITY
INSTITUTION
NET BUY (CR.)
NET SELL (CR)
FII
3914.10
3864.96
DII
1292.02
1282.47 NSE TOTALS
INDICES
ADVANCES
DECLINES
NIFTY
30
19
BANK NIFTY
5
7

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report r MARKET TALKS
Has improved sharply over past 5 years and under a best case scenario it can double in three to four years. ICICI Bank's return on equity is expected to rise from 14% to 18% by FY 2018.
 State Bank of Mysore soars 11% on robust Q2 nos.
Shares of State Bank of Mysore rallied 11% to Rs541 on BSE after reporting a more than three-fold jump in net profit at Rs102 crore in the July-September quarter (Q2) on higher interest income, lower provisions and better recovery from written-off accounts. The state- owned bank had profit of Rs 30 crore in the corresponding year-ago quarter.
 Jubilant Life sciences Q2 net loss at Rs941.10mn
Jubilant Life Sciences Ltd has posted a net profit/(loss) after taxes, minority interest and share in profit/(loss) of associates of Rs. (941.10) million for the quarter ended September 30, 2014 as compared to net loss of Rs. (805.80) mn for the quarter ended September 30, 2013. Total Income has decreased from Rs. 14412.50 million for the quarter ended September 30, 2013 to Rs. 13975.20 million for the quarter ended September 30, 2014.
 Ranbaxy: Boost from Q2 earnings, Top line beats estimates.
Ranbaxy announced its financial results for the second quarter ended 30 September 2014. The net profit of the Pharma company increased to Rs 478 crore as against the net loss of Rs. 454 crore in the same quarter last fiscal. During the period under review, the company's sales stood at Rs. 3218 crore as compared with Rs. 2750 crore.
 Lupin Q2 profit beats estimates; Consolidated net profit up 55% (YoY)
Lupin results for the quarter ended Sep 30, 2014 (YoY): Net profit of the company slipped by 43.19% to Rs459.62 cr Vs Rs809.12 cr (YoY). Total Income decreased by 7.61% to Rs2347.83 cr Vs Rs2541.48 cr (YoY).Net profit of the company rose by 55.11% to Rs630.04 cr Vs Rs406.18 cr (YoY).Total Income has increased by 19.43% to Rs3283.64 cr Vs Rs2749.23 cr (YoY).
 ICICI Bank gains on bullish stance by foreign brokerage
The foreign brokerage reportedly said that profitability of ICICI Bank
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary authority over your trading or investment accounts. All rights reserved.
DISCLAIMER